Airway clearance in bronchiectasis: a randomised crossover trial of ACBT versus TIRE

J. E. Patterson, J. M. Bradley, S. Elborn (Jordanstown, Belfast, United Kingdom)

Source: Annual Congress 2003 - Management of acute exacerbations in COPD
Session: Management of acute exacerbations in COPD
Session type: Thematic Poster Session
Number: 1585
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. E. Patterson, J. M. Bradley, S. Elborn (Jordanstown, Belfast, United Kingdom). Airway clearance in bronchiectasis: a randomised crossover trial of ACBT versus TIRE. Eur Respir J 2003; 22: Suppl. 45, 1585

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Airway clearance in bronchiectasis: a randomised crossover trial of active cycle of breathing techniques (ACBT) versus a new device
Source: Eur Respir J 2004; 24: Suppl. 48, 406s
Year: 2004

Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial
Source: Eur Respir J, 51 (1) 1701926; 10.1183/13993003.01926-2017
Year: 2018



Bubble-positive expiratory pressure improves sputum clearance in people with bronchiectasis: a randomised crossover trial
Source: International Congress 2017 – Airway clearance techniques and respiratory physiotherapy in hospitalized patients
Year: 2017


Airway hyperresponsiveness to mannitol as a predictor of treatment response to ciclesonide in patients with suspected asthma: A double-blind, randomised, placebo-controlled trial
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012

The effect of bronchodilators in the exercise capacity and thoracoabdominal mechanics of subjects with bronchiectasis: a randomized crossover, double-blinded, placebo-controlled trial
Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases
Year: 2020


Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Tiotropium treatment for bronchiectasis (ROBUST): a randomized, placebo-controlled, crossover trial
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017


A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis
Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis
Year: 2008


Azithromycin for the treatment of cough in idiopathic pulmonary fibrosis: A randomized controlled cross-over pilot trial.
Source: Virtual Congress 2020 – Chronic cough: only symptom or disease?
Year: 2020




Nasal high-flow therapy (NHFT) during exercise in patients with cystic fibrosis (CF): a randomized crossover trial
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020


Long term azithromycin treatment: A randomised placebo-controlled trial in non-CF bronchiectasis; results from the BAT trial
Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Year: 2011


Evaluation of ICS/LABA combination therapy on respiratory function in patients with asthma: Open-label, randomized, cross-over trial.
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Efficacy of airway clearance therapy with different autonomy degrees in nonCF-BE: Randomized cross-over trial
Source: Annual Congress 2011 - Chest physiotherapy and breathing retraining
Year: 2011



Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial
Source: ERJ Open Res, 7 (3) 00738-2020; 10.1183/23120541.00738-2020
Year: 2021



The effects of T-PEP on ventilation lung scan in patients with bronchiectasis: Protocol for a randomized controlled trial
Source: Annual Congress 2010 - Respiratory muscle function and training in acute and chronic respiratory disease
Year: 2010


Antibiotic in non-purulent hospitalised-treated exacerbations of COPD: a randomised double-blind placebo-controlled trial
Source: International Congress 2019 – Airway infection in COPD
Year: 2019

Late Breaking Abstract - Inhaled indacaterol does not affect lung function or symptoms in lymphangioleiomyomatosis: a double blind placebo controlled cross-over trial
Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases
Year: 2017



Resistance arm training in patients with COPD: A randomized controlled trial
Source: Annual Congress 2010 - Exercise training and pulmonary rehabilitation
Year: 2010

Diaphragmatic breathing training in COPD patients: A randomized, controlled and blinded trial
Source: Annual Congress 2010 - Respiratory muscles and breathing: assessment and training
Year: 2010


Budesonide versus prednisone in acute wheezing: randomized double-blinded controlled placebo study
Source: Annual Congress 2008 - Treatment and outcome of childhood asthma: new perspectives
Year: 2008